1)Kimberlin DW, Jester PM, Sánchez PJ, et al:Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 372:933-43,2015
2)Oliver SE, Cloud GA, Sánchez PJ, et al:Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 46(Suppl 4):S22-S26, 2009
3)Koyano S, Inoue N, Oka A, et al:Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open 1:e000118,2011
4)Revello MG, Gerna G:Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 15:680-715,2002
5)瀬山貴博,永松健,藤井知行:妊婦とサイトメガロウイルス.産と婦 81:481-485,2014
6)庵原俊昭,谷口清洲,神谷齊,他:ワクチン後のムンプス罹患例におけるムンプスIgG抗体とそのAvidityの検討.臨とウイルス 24:389-393,1996
7)de Vries JJ, van der Eijk AA, Wolthers KC, et al:Real-time PCR versus viral culture on urine as a gold standard in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 53:167-170,2012
8)森内浩幸:先天性CMV感染治療プロトコール.小児感染免疫 22:385-389,2010
9)母子感染の予防と診療に関する研究班(藤井班):妊娠中に感染しないために(http://cmvtoxo.umin.jp/public_02.html)(最終アクセス:2017年9月22日)
10)Hamprecht K, Maschmann J, Vochem M, et al:Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 357:513-518,2001
11)Bevot A, Hamprecht K, Krägeloh-Mann I, et al:Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk. Acta Paediatr 101:e167-e172,2012
12)Josephson CD, Caliendo AM, Easley KA, et al:Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study. JAMA Pediatr 168:1054-1062,2014
13)日本赤十字社血液事業本部安全管理課:Haemovigilance by JRCS 2013.(http://www.jcr.or.jp/mr/news/pdf/JRC_Haemovigilance2013_jp.pdf)(最終アクセス:2017年9月22日)